Stocktoria
Bausch Health Companies Inc. BHC
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 1994-09-20
Bausch Health Companies Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $10.3B | $9.6B | $8.8B | $8.1B | $8.4B |
| SG&A expense | $3.4B | $3.3B | $2.9B | $2.6B | $2.6B |
| Operating income | $1.8B | $1.5B | $963.0M | $454.0M | $450.0M |
| Income tax | $247.0M | $239.0M | $221.0M | $83.0M | -$87.0M |
| Net income | $157.0M | -$46.0M | -$592.0M | -$225.0M | -$948.0M |
| EPS (diluted) | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 |
| Operating cash flow | $1.4B | $1.6B | $1.0B | -$728.0M | $1.4B |
| Free cash flow | $1.0B | $1.3B | $817.0M | -$946.0M | $1.2B |
| Cash & equivalents | $1.3B | $1.2B | $947.0M | $564.0M | $582.0M |
| Inventory | $1.6B | $1.6B | $1.5B | $1.1B | $993.0M |
| Total assets | $26.4B | $26.5B | $27.4B | $25.7B | $29.2B |
| Total liabilities | $26.0B | $26.8B | $27.4B | $25.4B | $29.2B |
| Shareholders' equity | -$554.0M | -$1.3B | -$1.0B | -$692.0M | -$106.0M |
Source: SEC EDGAR filings · CIK 0000885590 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.